However, trastuzumab inhibits HER2 signaling by binding to HER2, leading to excessive accumulation of reactive oxygen species (ROS) and destruction of cardiomyocytes in the presence of excess organic oxygen species, leading even to cardiac insufficiency. This evidence concerns the gene ERBB2 and heart failure.